Investor Presentaiton

China Life Sciences - 2022 Growth drivers 000 Covid- 19/future pandemic •Vaccine development, testing, production and rollout are vital to the worldwide economic recovery. Ageing society •China's previous one-child policy has made it one of the fastest ageing countries in the world. Wealth •China accounts for 18% of the global wealth according to Credit Suisse, with expectations that this will grow faster than the US over the next five years. Government Support Government support will be a key driver for a new setup and development of life science parks and industry. ע VC/PE Investment Growths •New PE/VC funds in China's life science sector increased by nearly 90% in 2021. -958 Access to Talent Technology •Life science companies or R&D centres tend to cluster around leading academic institutions •Technologies such as Al, machine learning, CRISPR and mRNA are accelerating and reshaping the industry. Sustainability •Companies adopting sustainable strategies are more likely to gain support from government and global organisations. Short-term accelerators Long-term drivers Input factors Game changers

View entire presentation